Research Paper Volume 13, Issue 13 pp 17607—17628

Comprehensive analysis of an immune-related ceRNA network in identifying a novel lncRNA signature as a prognostic biomarker for hepatocellular carcinoma


Figure 5. Clinical characteristics with the lncRNA prognostic signature in the entire TCGA-LIHC cohort. (A) Distribution of clinicopathologic features, and lncRNA expression in the low-risk and high-risk groups; (B) time-dependent ROC curves and AUC for 5-year overall survival.